Susquehanna International Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,518
| Closed | -$1.28M | – | 6644 |
|
|
2024
Q4 | $1.28M | Buy |
47,518
+4,252
| +10% | +$115K | ﹤0.01% | 2630 |
|
|
2024
Q3 | $1.25M | Buy |
43,266
+19,188
| +80% | +$553K | ﹤0.01% | 2406 |
|
|
2024
Q2 | $656K | Buy |
24,078
+6,162
| +34% | +$168K | ﹤0.01% | 3126 |
|
|
2024
Q1 | $502K | Sell |
17,916
-13,712
| -43% | -$384K | ﹤0.01% | 3540 |
|
|
2023
Q4 | $842K | Buy |
31,628
+19,444
| +160% | +$518K | ﹤0.01% | 3098 |
|
|
2023
Q3 | $312K | Sell |
12,184
-28,917
| -70% | -$739K | ﹤0.01% | 3996 |
|
|
2023
Q2 | $1.08M | Buy |
41,101
+474
| +1% | +$12.4K | ﹤0.01% | 2617 |
|
|
2023
Q1 | $1.06M | Buy |
40,627
+31,172
| +330% | +$814K | ﹤0.01% | 2803 |
|
|
2022
Q4 | $259K | Buy |
+9,455
| New | +$259K | ﹤0.01% | 4103 |
|
|
2022
Q3 | – | Sell |
-24,675
| Closed | -$652K | – | 6403 |
|
|
2022
Q2 | $652K | Sell |
24,675
-27,373
| -53% | -$723K | ﹤0.01% | 3008 |
|
|
2022
Q1 | $1.39M | Buy |
52,048
+24,178
| +87% | +$643K | ﹤0.01% | 2443 |
|
|
2021
Q4 | $755K | Sell |
27,870
-28,296
| -50% | -$767K | ﹤0.01% | 3229 |
|
|
2021
Q3 | $1.44M | Buy |
56,166
+16,125
| +40% | +$412K | ﹤0.01% | 2321 |
|
|
2021
Q2 | $1.04M | Buy |
40,041
+19,814
| +98% | +$513K | ﹤0.01% | 2930 |
|
|
2021
Q1 | $516K | Sell |
20,227
-16,051
| -44% | -$409K | ﹤0.01% | 3802 |
|
|
2020
Q4 | $935K | Buy |
36,278
+20,424
| +129% | +$526K | ﹤0.01% | 2660 |
|
|
2020
Q3 | $379K | Sell |
15,854
-8,929
| -36% | -$213K | ﹤0.01% | 3286 |
|
|
2020
Q2 | $567K | Sell |
24,783
-7,522
| -23% | -$172K | ﹤0.01% | 2797 |
|
|
2020
Q1 | $644K | Buy |
+32,305
| New | +$644K | ﹤0.01% | 2585 |
|
|
2019
Q2 | – | Sell |
-26,559
| Closed | -$568K | – | 4683 |
|
|
2019
Q1 | $568K | Buy |
+26,559
| New | +$568K | ﹤0.01% | 1747 |
|
|
2017
Q4 | – | Sell |
-56,488
| Closed | -$1.13M | – | 3952 |
|
|
2017
Q3 | $1.13M | Buy |
56,488
+33,811
| +149% | +$677K | ﹤0.01% | 1572 |
|
|
2017
Q2 | $469K | Buy |
+22,677
| New | +$469K | ﹤0.01% | 2437 |
|